JOA - 2026-11-01 - Journal Article
Treatment Failure Rates Decrease Significantly at Approximately One Year Following Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection.
Shannon MF, Rothenberger SD, Drummond EF, Wong VR, Urish KL
Topics
Key Takeaway
Two-stage exchange arthroplasty for chronic TKA PJI demonstrates a 441% higher failure rate before 1.20 years post-reimplantation, with a secondary breakpoint at 2.42 years identifying a 7.40-fold higher failure rate in the first year versus beyond 2.42 years.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This retrospective study of 148 patients undergoing two-stage exchange arthroplasty for chronic TKA PJI used Bayesian regression with Monte Carlo Markov Chain simulations to identify statistically significant breakpoints in cumulative failure curves using 2019 MSIS Outcome Reporting Tool criteria. For the broad tier 1 failure definition (including suppressive antibiotic patients), a single breakpoint at 1.20 years (95% CI: 1.03–1.47) captured a 441% higher pre-breakpoint failure rate; a two-breakpoint model identified inflection points at 1.11 and 2.42 years with failure rates 3.43× and 7.40× higher in the earliest interval. For the stricter tier 1-plus-2 definition, a single breakpoint at 0.73 years was associated with a 997% higher pre-breakpoint failure rate, indicating that most clinically overt failures occur within the first year.
Key Limitation
Single-institution retrospective design with no stratification by infecting organism, spacer type (static vs. articulating), or antibiotic regimen prevents identification of which patient or treatment factors drive early versus late failure clustering.
Original Abstract
BACKGROUND
The two-stage exchange arthroplasty is a preferred treatment for chronic periprosthetic joint infection (PJI). A gap in knowledge remains surrounding the optimal follow-up period for staged revision. This study aimed to determine the length of time PJIs should be monitored after two-stage exchange arthroplasty and the timepoints by which most failures occur.
METHODS
This retrospective study evaluated 148 patients who underwent two-stage exchange arthroplasty for chronic total knee arthroplasty PJI from 2015 to 2022. Dates of failure were recorded using the 2019 Musculoskeletal Infection Society Outcome Reporting Tool criteria. Bayesian regression with Monte Carlo Markov Chain simulations was used to generate simulation models with one or two statistically significant breakpoints in cumulative failure curves. "Tier 1 failure" included patients on suppressive antibiotics; "tier 1 plus 2 failure" excluded them, with tier 3 and 4 cases classified as failures in both models.
RESULTS
For tier 1 failure, we identified a significant breakpoint at 1.20 years (95% confidence interval: 1.03 to 1.47), with a 441% greater failure rate before this point (P < 0.001). A two-breakpoint model identified breakpoints at 1.11 and 2.42 years; failure was 3.43 times higher before 1.11 years than between 1.11 and 2.42 years and 7.40 times higher than after 2.42 years (P < 0.001). For tier 1 plus 2 failure, a single breakpoint at 0.73 years (95% confidence interval: 0.62 to 1.06) was associated with 997% higher failure than before this time (P < 0.001). Single breakpoint models demonstrated superior overall fit.
CONCLUSIONS
Failures clustered early, with steep first-year accrual for the tier 1 plus 2 endpoint, while Tier 1 reoperation failures continued to accumulate into the second year. Breakpoints mark the onset of declining failure rates, rather than complete elimination of risk. Thus, 1-year follow-up may be adequate for studies using broad failure definitions, while extended follow-up into the second postoperative year remains essential to fully characterize late failures.